about
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.Real-Time Monitoring of Psychotherapeutic Processes: Concept and ComplianceTranslation of ERC resuscitation guidelines into clinical practice by emergency physicians.Development and validation of a patient safety culture questionnaire in acute geriatric units.GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure.Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome.NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.Long-term outcome after thrombectomy in acute myocardial infarction.Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment.Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.The effectiveness of ERC advanced life support (ALS) provider courses for the retention of ALS knowledge.Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy.N-terminal B-type natriuretic peptide (NT-proBNP) is associated with disease severity in multiple myeloma.Low- and High-renin Heart Failure Phenotypes with Clinical Implications.A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus.Learning curve for the detection of pouch of Douglas obliteration and deep infiltrating endometriosis of the rectum.Phase transitions between lower and higher level management learning in times of crisis: an experimental study based on synergetics.The synchronization of plan activations and emotion-abstraction patterns in the psychotherapeutic process: a single-case study.PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.The identification of critical fluctuations and phase transitions in short term and coarse-grained time series-a method for the real-time monitoring of human change processes.Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.[Dynamic evaluation of the effects of quality management].Evolution of secondary mitral regurgitation.Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failureNT-proBNP as a means of triage for the risk of hospitalisation in primary careSerum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitusParameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunctionThe circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patientsCost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse careNT-proBNP and cardiac events in older diabetic patients[Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany]
P50
Q30434636-BBE2E520-2D98-442E-89D1-E40D2712BE86Q34012825-6B7F2033-BB52-4577-AF84-96DD716F1914Q36859773-B44E2588-8E2D-48FC-B58B-03629538D1C9Q37539846-BEED9AEE-2421-45F2-B579-5126BC2AC0F4Q37801792-1ED4A092-B7D7-4BD3-9D16-809630DE4654Q38809246-9843F9A0-48E0-40CD-B73F-65C447AA4F93Q38838027-285B4AC3-3DA1-4909-BDE9-E9B90E685626Q38844926-F72EE71B-4A08-4764-BC83-E2B8BEA726EDQ38861099-1E016804-35EC-45B7-8107-C6C874DFFF8EQ39735496-DA3E198A-6DD0-4D3C-A65E-935359217309Q41293101-62D0E5E7-05BF-4DC0-9615-1C7F6686955CQ42663968-7D4765C2-198C-4C16-8A7B-4CD436CA2A57Q43540678-825A1BC8-6C2C-4C43-A1C1-8CAAA00F2ED8Q43990488-4727EF98-B389-4CE4-AD0B-A8C21B7928F0Q44444286-45ED5D1B-1A88-4442-97B5-ABF7C9A661E3Q45262893-F6BC54F2-084D-46AF-91C9-D2DEF33EA731Q45765980-09D46B84-980B-44D3-B877-CB9E2408A64CQ47567410-183FFE82-CFF7-4D81-B554-7C5408CBE611Q48226173-9C2E270D-0412-46F8-9C84-2771F3946E70Q48418608-C367440D-B59D-4A1A-ACFD-6E2B3F5D71D4Q48502566-50BEDA58-A60E-4299-B194-E6DD5AEA2563Q48600854-AB86048B-7FF4-4224-852C-2D507507DE17Q48940554-2DE9C162-B22D-4B3D-AC22-E658E427F588Q50666831-F81C9D96-43ED-41E8-9EA7-6B757DB3D47BQ50723700-83E3BCF1-5B7E-48C9-BE7A-8199B0DC05CFQ50724408-4BD8E1FD-ED7B-4FE2-8B87-F2255DDB1F15Q50869983-1C839BFD-E700-470A-8244-5671860FB3B5Q51728249-1E0ABE16-B10B-4366-8B72-0A83C4D4BAEAQ51842560-90BAC50F-C3CD-44AA-908C-32DF9DCF74CAQ51953077-3398D8D9-32D0-4233-BA8C-D668C27BEDDAQ52357356-B1F33BFE-7C7B-47F5-8DB0-F0AF4CAF681BQ54299465-4A098631-5E4E-4AD4-B3FD-AF07CFC6322EQ57909796-2C8F9E29-DB36-4313-B7A0-EB9E21D5F9B0Q58071129-BE2CBC33-472F-4A48-95E3-B90B58AD9994Q58788250-024F2492-5D33-4E43-933D-AF819097048CQ59796559-CD69FFB0-2BDA-4A53-99A7-888F60BA3A6DQ64116225-287B8036-1292-4507-8B61-905E25C0238AQ82424339-EDA60585-99DD-4BD2-9687-A29BF0424471Q83750024-1490E289-1826-483E-A7C2-0B6004BDAEA1Q83802287-67F84822-84D6-40DB-B388-D16E5C76A1D3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Guido Strunk
@ast
Guido Strunk
@en
Guido Strunk
@es
Guido Strunk
@nl
Guido Strunk
@sl
type
label
Guido Strunk
@ast
Guido Strunk
@en
Guido Strunk
@es
Guido Strunk
@nl
Guido Strunk
@sl
prefLabel
Guido Strunk
@ast
Guido Strunk
@en
Guido Strunk
@es
Guido Strunk
@nl
Guido Strunk
@sl
P106
P21
P31
P496
0000-0002-0607-5105